Old Web
English
Sign In
Acemap
>
authorDetail
>
Daisuke Ozawa
Daisuke Ozawa
Colorectal cancer
Medicine
Internal medicine
Tipiracil
Trifluridine
4
Papers
9
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Post-marketing surveillance study of trifluridine/tipiracil in patients with metastatic colorectal cancer.
2021
Japanese Journal of Clinical Oncology
Takayuki Yoshino
Hiroyuki Uetake
Yuya Funato
Yasunobu Yamaguchi
Takahiko Koyama
Daisuke Ozawa
Masaru Tajiri
Kei Muro
Show All
Source
Cite
Save
Citations (0)
Rationale and design of the TRUSTY study: a randomised, multicentre, open-label phase II/III study of trifluridine/tipiracil plus bevacizumab versus irinotecan, fluoropyrimidine plus bevacizumab as second-line treatment in patients with metastatic colorectal cancer progressive during or following first-line oxaliplatin-based chemotherapy
2018
Takayuki Yoshino
Eiji Oki
Hiroaki Nozawa
Takako Eguchi Nakajima
Hiroya Taniguchi
Satoshi Morita
Naruhito Takenaka
Daisuke Ozawa
Kuniaki Shirao
Show All
Source
Cite
Save
Citations (8)
TRUSTY: A randomized multicenter phase II/III study of trifluridine/tipiracil and bevacizumab versus irinotecan, fluoropyrimidine, and bevacizumab as second-line treatment in patients with metastatic colorectal cancer progressive during or following first-line oxaliplatin-based chemotherapy.
2018
Journal of Clinical Oncology
Takayuki Yoshino
Eiji Oki
Hiroaki Nozawa
Takako Eguchi Nakajima
Hiroya Taniguchi
Satoshi Morita
Naruhito Takenaka
Daisuke Ozawa
Kuniaki Shirao
Show All
Source
Cite
Save
Citations (1)
Background Image Estimation by Pixel Luminance Changing
1995
Daisuke Ozawa
Shuji Hashimoto
Akiyoshi Tanaka
Show All
Source
Cite
Save
Citations (0)
1